Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia

NCT05568654 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05568654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05568654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2022
Completion date
June 30, 2026
Enrollment
28,580 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

antimicrobial stewardship, community-acquired pneumonia, point-of-care testing